Ad
related to: drug identifier
Search results
Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929...
FOX 5 San Diego· 7 days agoThe data will be presented in a poster at the 2024 American Society...
Pronouns and tribal affiliations are now forbidden in South Dakota public university employee emails
KSNT Topeka· 6 days agoA new South Dakota policy to stop the use of gender pronouns by public university faculty and staff...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days ago- Beneficial clinical responses observed with EO2463 monotherapy already at 6 weeks and complete response rate of 78% in patients treated with EO2463 upon addition of lenalidomide ± rituximab - EO2463 rapidly expands memory CD8+ T cells specific
